Stay updated with breaking news from Affinivax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON (dpa-AFX) - GSK plc (GSK.L) on Tuesday said it has completed the acquisition of clinical-stage biopharmaceutical company Affinivax, Inc. The definitive deal was announced by GSK in May this
LONDON, May 31 — British drugmaker GlaxoSmithKline today snapped up US biopharmaceutical firm Affinivax for up to US$3.3 billion (RM14 billion), expanding further into vaccines...
(Getty / E+ / Geber86) After getting off a meaty $120 million round in April, the height of the first wave of COVID-19 infections in the West, Affinivax is a clear indicator that infectious disease and vaccine work is here to stay. Nearly doubling that already impressive B round, the Cambridge, Massachusetts-based biotech has nabbed $226 million, with goals of unseating Pfizer’s Prevnar franchise as well as pushing a set of vaccines for hospital-associated infections into the clinic. Its lead program works as a Prevnar 13 challenger that covers 24 strains of pneumococcus and is full...